BDAZ - All of the phase II trials were EMA trials as the FDA never approved them on the cardio side. If the Renal side of the FDA approves this trial it will give the cardio side a better chance (IMO) of have the BETonMACE Phase III trial being approved by the FDA. As there is more $$ spent on drugs in the USA than any other country in the world this would double our potential sales and thus our valuation. I am willing to and have indeed made a big bet that this will be the case.

Between FDA approvals, financing certainty and Futility Study results we could have a very interesting few months ahead of us. DYODD

tada